Form 4 for CRL Charles River Laboratories
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-20 · accession 0001127602-25-006253 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-20 | CRL | FOSTER JAMES C | COB, Pres, CEO, Dir | P - Purchase | $165.01 | +6,075 | 183.6K | +3% | +$1.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | P | A | 6,075 | $165.01 | 183,639 | D | — | — |